Delivery Order SPE2DB22D1002-SPE2DB25FLFC2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,949.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,357.20 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.70 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award, indicating the product was procured through an existing contract vehicle rather than a new...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials) with a ceiling value of $1,342.88. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $2,138.48 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under the company's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a $1,203.64 delivery order to AmerisourceBergen Drug Corp for MENVEO A-C-Y-W Kit (2 Vials) with a firm fixed price structure and an ultimate completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The MENVEO vaccine represents a critical medical supply supporting military healthcare readiness and immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFC2Delivery Order
The Defense Logistics Agency awarded a $3,633.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), with an ultimate completion date of July 23, 2025. This competitively awarded contract, with no set-aside designation, represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued on July 22, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Menveo vaccine delivery reflects the company's role as a critical federal medical vendor, fulfilling recurring pharmaceutical requirements across the Defense Health Agency and broader military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/22/25 |